We are live on
!
Find out more
Utah Medical Products
UTMD
UTMD
55 hedge funds and large institutions have $124M invested in Utah Medical Products in 2013 Q2 according to their latest regulatory filings, with 55 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+55
Holders Change %
–
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
55
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Ameriprise
Minneapolis,
Minnesota
| $11K | +$9.7K | +206 | New |
|
52
Schroder Investment Management Group
London,
United Kingdom
| $10.9K | +$9.41K | +200 | New |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $10K | +$8.8K | +187 | New |
|
|
RFC
54
Russell Frank Company
Seattle,
Washington
| $1K | +$894 | +19 | New |
|
55
Citigroup
New York
| – | +$188 | +4 | New |
|
UTMD Hedge Fund Activity: Q2 2013 in Review
55 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2013, worth a combined $124M.
Buyers outnumbered sellers: 55 funds opened new UTMD positions and 0 closed out — a net gain of 55 holders — while 0 added to existing stakes and 0 trimmed.
- 55 institutional investors held Utah Medical Products (UTMD) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $124M of Utah Medical Products stock for Q2 2013.
- 55 funds opened new Utah Medical Products positions in Q2 2013 and 0 closed out, a net change of +55 holders.
Based on aggregated 13F filings for Q2 2013.